JDD HighlightsJDD in the MediaThe Latest

JDD in the News: Chlorophyll for Clear Skin, Depression & Isotretinoin

By May 26, 2021July 15th, 2021No Comments

In The News

In the News

JDD Impact Factor and Influence

The Journal of Drugs in Dermatology is featured in two recent articles about the latest TikTok trend — chlorophyll.

More on Chlorophyll

The Journal of Drugs in Dermatology in the News 

Allison Sit

The Journal of Drugs in Dermatology is featured in two recent articles about the latest TikTok trend — chlorophyll. Users claim products that contain chlorophyllin – a water-soluble version of chlorophyll — clear the skin, reduce bloating and help with weight loss. Both articles, “Liquid Chlorophyll: What to Know Before Buying,” by NBC News, and “Should You Hop on the Chlorophyll Wellness Trend?” by L’Officiel address the nutritional benefits of chlorophyll and ways to consume more of it.

The articles both cite a 2015 JDD study, “Pilot Study of Topical Copper Chlorophyllin Complex in Subjects With Facial Acne and Large Pores,” by Thomas J. Stephens, PhD, John P. McCook, and Dr. James H. Herndon, Jr. The study found a topical formulation containing a liposomal dispersion of sodium copper chlorophyllin complex to be clinically effective and well tolerated for the treatment of mild to moderate acne and large, visible pores when used for 3 weeks.

Dermatology Times highlighted a JDD study in its article, “Depression, Distress Different Between Patients Treated with Isotretinoin and Oral Antibiotics.” The article cites a February 2021 study, “Differences in Depression and Distress Between Acne Patients on Isotretinoin vs Oral Antibiotics” by Dr. April Armstrong and researchers. The study analyzed acne patients’ responses to Patient Health Questionnaire 2 and the Kessler 6-Item Psychological Distress Scale. Researchers found acne patients on isotretinoin experienced fewer depressive symptoms and psychological distress compared to patients on oral antibiotics.

The Dermatology Digest also wrote about the JDD study on depression and isotretinoin in its April print edition. The publication also published briefs on two other 2021 JDD articles, “Laboratory Testing in Telogen Effluvium,” and “Intralesional 5-Fluorouracil for Treatment of Non-Melanoma Skin Cancer: A Systematic Review.”

You May Also Like

Journal of Drugs in Dermatology JDD Article About Injectable Minoxidil for Hair Loss Disorders: A Systematic Review

Injectable Minoxidil for Hair Loss Disorders: A Systematic Review

| Featured Articles, The Latest | No Comments
JDD Latest News Could injectable minoxidil revolutionize hair loss management? While widely used in topical and oral forms, its injectable counterpart is garnering attention for treating conditions like androgenetic alopecia and…
Journal of Drugs in Dermatology JDD Article About Practical Update on Treatment of Oral Candidiasis

Practical Update on Treatment of Oral Candidiasis

| Featured Articles, The Latest | No Comments
JDD Online Exclusive As new psoriasis treatments expand, so do potential side effects like oral candidiasis. This common yet manageable condition may present with distinctive symptoms, such as burning sensations or…
Journal of Drugs in Dermatology JDD Article About Recognizing and Advancing Leadership in Dermatology: Promoting the Health Care Administration, Leadership, and Management Subspecialty

Recognizing and Advancing Leadership in Dermatology: Promoting the Health Care Administration, Leadership, and Management Subspecialty

| Featured Articles, The Latest | No Comments
JDD Article Highlights The launch of the Health Care Administration Leadership and Management (HALM) subspecialty in 2023 is poised to redefine leadership in dermatology. Supported by the American Board of…

Leave a Reply